Visara appoints ophthalmology leaders to advance VIS-101 drug program
Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program| (NASDAQ: AURA) | Delayed: 6.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.46 | 52 Week High | $ | |||
| Open | $6.46 | 52 Week Low | $ | |||
| Day High | $6.46 | P/E | N/A | |||
| Day Low | $6.46 | EPS | $ | |||
| Volume | 24 | |||||
| (NASDAQ: FDMT) | Delayed: 12.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.59 | 52 Week High | $ | |||
| Open | $12.59 | 52 Week Low | $ | |||
| Day High | $12.59 | P/E | N/A | |||
| Day Low | $12.59 | EPS | $ | |||
| Volume | 31 | |||||
| (NASDAQ: NBP) | Delayed: 1.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.37 | 52 Week High | $6.95 | |||
| Open | $1.37 | 52 Week Low | $6.95 | |||
| Day High | $1.37 | P/E | 0.64 | |||
| Day Low | $1.37 | EPS | $2.14 | |||
| Volume | 708 | |||||



